News

Mitotic rate makes comeback as melanoma prognosticator
- Author:
- Bruce Jancin
Key insight: the relationship between mitotic rate and melanoma survival is nonlinear.
News
Improvements in chronic hand eczema seen with oral gusacitinib in phase 2 study
- Author:
- Bruce Jancin
The rapidity of response was noteworthy in these steroid-refractory patients.
News
Tildrakizumab for psoriasis shows durable efficacy over 5 years
- Author:
- Bruce Jancin
Few left long-term extension study because of adverse events or loss of efficacy.
News

Inattention to heightened CV risk common theme in clozapine deaths teaser
- Author:
- Bruce Jancin
“Inadequate treatment for metabolic syndrome was found to be a mortality predictor while on clozapine therapy,” said Dr. Sharon Taub.
News

New-onset AFib common but unrecognized in the month after cardiac surgery
- Author:
- Bruce Jancin
Results of SEARCH-AF trial show one in five cardiac surgery patients with no history of atrial fibrillation develop it within 30 days post...
News
Siblings of patients with bipolar disorder at increased risk
- Author:
- Bruce Jancin
“Strategies to prevent onset of psychiatric illness in individuals with a first-generation family history ... should be lifelong,” said Dr. Lars...
News

Chronic inflammatory diseases vary widely in CHD risk
- Author:
- Bruce Jancin
The highest coronary heart disease risks linked to inflammation are seen in SLE and systemic sclerosis, conditions that aren’t included in...
News

Clopidogrel bests ticagrelor head-to-head for elective PCI in ALPHEUS
- Author:
- Bruce Jancin
Ticagrelor doesn’t reduce periprocedural myonecrosis, as hypothesized, but does cause more minor bleeding.
News
TIPS-3: Polypill provides meaningful primary cardiovascular prevention
- Author:
- Bruce Jancin
“You’re seeing a paradigm shift right here in front of your eyes today. This could be a game changer in terms of preventing large numbers of...
News

What happened to melanoma care during COVID-19 sequestration
- Author:
- Bruce Jancin
Preliminary evidence indicates delayed diagnosis and treatment measurably worsened outcome indicators.
News

Abrocitinib highly effective as long-term monotherapy in AD
- Author:
- Bruce Jancin
JADE EXTEND study shows nearly 90% EASI-75 rate at 48 weeks.
News
Smartphones can differentiate bipolar from borderline personality disorder
- Author:
- Bruce Jancin
“It doesn’t replace doctors, but clearly it can add to diagnostic accuracy,” said Dr. Kate E.A. Saunders.
News

Topical tapinarof effective in pivotal psoriasis trials
- Author:
- Bruce Jancin
Efficacy was comparable with potent topical corticosteroids, but without the side-effects baggage.
News

Who’s at risk for depression on isotretinoin?
- Author:
- Bruce Jancin
Large Scottish study concludes prior depressive history is the sole predictor.
News
PARTNER registry valve-in-valve outcomes reassuring at 5 years
- Author:
- Bruce Jancin
“This information is changing our algorithm for how we initially make treatment decisions in our patients.” – Dr. Rebecca T. Hahn